HLA-G 14bp deletion/insertion polymorphism and mother-to-child transmission of HIV

Tissue Antigens

Volumn 83, Issue 3, 2014, Pages 161-167

  Segat, L ^a   Zupin, L ^a   Kim, H Y ^c   Catamo, E ^b   Thea, D M ^d   Kankasa, C ^e   Aldrovandi, G M ^f   Kuhn, L ^c   Crovella, S ^a,b  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c Vagelos College of Physicians and Surgeons   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY TEACHING HOSPITAL   (Zambia)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

14bp insertion deletion; Genetic polymorphism; Human immunodeficiency virus 1; Human leukocyte antigen G; Vertical transmission

Indexed keywords

HLA G ANTIGEN;

14 BP INSERTION/DELETION; ADULT; ALLELE; ARTICLE; BASE PAIRING; CHILD; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS-1; HUMAN LEUKOCYTE ANTIGEN-G; IMMUNOLOGY; INDEL MUTATION; INFANT; MOTHER; VERTICAL TRANSMISSION; YOUNG ADULT;

14 BP INSERTION/DELETION; GENETIC POLYMORPHISM; HUMAN IMMUNODEFICIENCY VIRUS-1; HUMAN LEUKOCYTE ANTIGEN-G; VERTICAL TRANSMISSION;

ADULT; ALLELES; BASE PAIRING; CHILD; GENOTYPE; HIV INFECTIONS; HLA-G ANTIGENS; HUMANS; INDEL MUTATION; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MOTHERS; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 84894237626     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12296     Document Type: Article

References (39)

1. World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Geneva: WHO Library, 2010.
2. Newell M-L, Thorne C. Antiretroviral therapy and mother-to-child transmission of HIV-1. Expert Rev Anti Infect Ther 2004: 2: 717-32.
3. Chi BH, Adler MR, Bolu O et al. Progress, challenges, and new opportunities for the prevention of mother-to-child transmission of HIV under the US President's Emergency Plan for AIDS Relief. J Acquir Immune Defic Syndr 2012: 60 (Suppl 3): S78-87.
4. De Andreis C, Simoni G, Rossella F et al. HIV-1 proviral DNA polymerase chain reaction detection in chorionic villi after exclusion of maternal contamination by variable number of tandem repeats analysis. AIDS 1996: 10: 711-5.
5. Zachar V, Zacharova V, Fink T et al. Genetic analysis reveals ongoing HIV type 1 evolution in infected human placental trophoblast. AIDS Res Hum Retroviruses 1999: 15: 1673-83.
6. Menu E, Mbopi-Keou FX, Lagaye S et al. Selection of maternal human immunodeficiency virus type 1 variants in human placenta. European Network for In Utero Transmission of HIV-1. J Infect Dis 1999: 179: 44-51.
7. Moussa M, Mognetti B, Dubanchet S et al. Vertical transmission of HIV: parameters which might affect infection of placental trophoblasts by HIV-1: a review. Biomed Group on the Study of in Utero Transmission of HIV 1. Am J Reprod Immunol 1999: 41: 312-9.
8. Bourinbaiar AS, Nagorny R. Human immunodeficiency virus type 1 infection of choriocarcinoma-derived trophoblasts. Acta Virol 1993: 37: 21-8.
9. Kilani RT, Chang LJ, Garcia-Lloret MI, Hemmings D, Winkler-Lowen B, Guilbert LJ. Placental trophoblasts resist infection by multiple human immunodeficiency virus (HIV) type 1 variants even with cytomegalovirus coinfection but support HIV replication after provirus transfection. J Virol 1997: 71: 6359-72.
10. Tscherning-Casper C, Papadogiannakis N, Anvret M et al. The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J Virol 1999: 73: 9673-8.
11. Lagaye S, Derrien M, Menu E et al. Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection. J Virol 2001: 75: 4780-91.
12. Kourtis AP, Lee FK, Abrams EJ, Jamieson DJ, Bulterys M. Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis 2006: 6: 726-32.
13. Matt C, Roger M. Genetic determinants of pediatric HIV-1 infection: vertical transmission and disease progression among children. Mol Med 2001: 7: 583-9.
14. Hviid TVF. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update 2006: 12: 209-32.
15. Menicucci A, Noci I, Fuzzi B et al. Non-classic sHLA class I in human oocyte culture medium. Hum Immunol 1999: 60: 1054-7.
16. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997: 94: 11520-5.
17. LeMaoult J, Caumartin J, Daouya M et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007: 109: 2040-8.
18. Blaschitz A, Juch H, Volz A et al. The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms. Mol Hum Reprod 2005: 11: 699-710.
19. Moodley S, Bobat R. Expression of HLA-G1 at the placental interface of HIV-1 infected pregnant women and vertical transmission of HIV. Placenta 2011: 32: 778-82.
20. Luo M, Czarnecki C, Ramdahin S, Embree J, Plummer FA. HLA-G and mother-child perinatal HIV transmission. Hum Immunol 2013: 74: 459-63.
21. Fabris A, Catamo E, Segat L et al. Association between HLA-G 3'UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children. AIDS 2009: 23: 177-82.
22. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymor-phism in the 30 UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003: 64: 1005-10.
23. Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001: 57: 15-24.
24. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003: 55: 63-79.
25. World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach. Geneva: WHO Library, 2010.
26. Martinetti M, Pacati I, Cuccia M et al. Hierarchy of baby-linked immunogenetic risk factors in the vertical transmission of hepatitis C virus. Int J Immunopathol Pharmacol 2006: 19: 369-78.
27. Robert-Gangneux F, Gangneux JP, Vu N, Jaillard S, Guiguen C, Amiot L. High level of soluble HLA-G in amniotic fluid is correlated with congenital transmission of Toxoplasma gondii. Clin Immunol 2011: 138: 129-34.
28. Svendsen SG, Hantash BM, Zhao L et al. The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3'-untranslated region. Hum Immunol 2013: 74: 818-27.
29. Mendes-Junior CT, Castelli EC, Meyer D, Simões AL, Donadi EA. Genetic diversity of the HLA-G coding region in Amerindian populations from the Brazilian Amazon: a possible role of natural selection. Genes Immun October 2013.
30. Tao Y, Chen J, Yao Y et al. Distribution of HLA-G 14-bp insertion/deletion polymorphism in six Chinese ethnic groups. Int J Immunogenet 2013: 40: 93-8.
31. Alves-Silva J, da Silva SM, Guimaraes PE et al. The ancestry of Brazilian mtDNA lineages. Am J Hum Genet 2000: 67: 444-61.
32. Kourtis AP, Ibegbu CC, Wiener J et al. Role of intestinal mucosal integrity in HIV transmission to infants through breast-feeding: the BAN study. J Infect Dis 2013: 208: 653-61.
33. Kwiek JJ, Mwapasa V, Milner DA Jr et al. Maternal-fetal microtransfusions and HIV-1 mother-to-child transmission in Malawi. PLoS Med 2006: 3: e10.
34. Mackelprang RD, John-Stewart G, Carrington M et al. Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. J Infect Dis 2008: 197: 1156-61.
35. Polycarpou A, Ntais C, Korber BT et al. Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type 1 transmission. AIDS Res Hum Retroviruses 2002: 18: 741-6.
36. MacDonald KS, Embree J, Njenga S et al. Mother-child class I HLA concordance increases perinatal human immunodeficiency virus type 1 transmission. J Infect Dis 1998: 177: 551-6.
37. Matte C, Zijenah LS, Lacaille J, Ward B, Roger M. Mother-to-child human leukocyte antigen G concordance: no impact on the risk of vertical transmission of HIV-1. AIDS 2002: 16: 2491-4.
38. Aikhionbare FO, Kumaresan K, Shamsa F, Bond VC. HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission. AIDS Res Ther 2006: 3: 28.
39. Larsen MH, Zinyama R, Kallestrup P et al. HLA-G 3' untranslated region 14-base pair deletion: association with poor survival in an HIV-1-infected Zimbabwean population. J Infect Dis 2013: 207: 903-6.